The global Zika Virus Market size is expected to reach USD 328.3 million in 2028 and register a CAGR of 7.9% according to the latest report by Reports and Data. Rising prevalence of Zika virus and growing adoption of technologically advanced tests across several countries are key factors driving global market revenue growth.

Zika virus is a member of Flaviviridae family, which is transmitted by daytime active Aedes mosquitoes, causative agents of various infections including fever, Japanese encephalitis, yellow fever, and dengue. Joint and muscle pain, rash, conjunctivitis, fever, and headache are some of the common systems of Zika virus infection. It can be transmitted from one person to another through sexual contact or from infected mother to fetus. Infected pregnant women have high risks of miscarriage, preterm birth, or serious birth defects including microcephaly or other congenital brain abnormalities. This has encouraged Zika Virus among pregnant women. Increasing investments by market players in research and development activities to develop innovative and advanced tests and growing public awareness about Zika virus infection, transmission, and benefits of early decision are fueling global market growth.  

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4040

Some key highlights in the report:

• Based on type, the serological testing segment accounted for largest share in 2020 and is expected to account for significant revenue share over the forecast period. These tests are extremely precise and can detect acute and late-stage Zika virus.  
• Among the end-use segments, the research institutes segment is projected to account for significant revenue growth between 2021 and 2028. Research institutes, such as NIAID and NIH, are collaborating with various organizations and pharmaceutical biotechnology companies to have a clear understanding of the virus and to develop advanced testing kits. Moreover, increasing funds for research and development activities are further fueling segment growth.
• Asia Pacific market is projected to account for fastest revenue growth during the forecast period. Increasing awareness about Zika virus and benefits of early detection, growing research on infection, initiatives from governments for improving the healthcare system, and increasing investments in RD activities are a few factors boosting global revenue growth.  
• The market in Latin America is expected to account for a considerably high revenue growth throughout the forecast period owing to factors such as rising prevalence of Zika virus infection, growing government initiatives to create awareness about the disease, and increasing research on developing advanced tests. 

Competitive Outlook of the Global Zika Virus Market

The globla Zika Virus market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Zika Virus market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Abbott Laboratories, Altona Diagnostics GmbH, Chembio Diagnostic Systems Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, Luminex Corporation, Novacyt Group, Quest Diagnostics, and Siemens AG.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4040

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Zika Virus Market Segmentation:

Test Type Outlook (Revenue, USD Million, 2018-2028)

• Molecular Testing
  • Nucleic Acid Amplification Testing (NAAT)
  • Polymerase Chain Reaction (PCR)
• Serological Testing
  • Enzyme-Linked Immune Sorbent Assay (ELISA)
  • Plaque Reduction and Neutralization Test (PRNT)

End-Use Outlook (Revenue, USD Million, 2018-2028)

• Diagnostic Laboratory
• Hospital and Clinics
• Research Institutes

Key Regional Markets Covered in the Report:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4040

Thank you for reading our report. To know more about the customization of the report, please get in touch with us and our team will ensure the report is suited to your requirements.

Get Explore Latest Research Report by Reports and Data:

Ependymoma Treatment Market @ https://www.biospace.com/article/rising-demand-for-disease-specific-novel-treatments-is-expected-to-drive-ependymoma-treatment-market-growth-by-2030-reports-and-data/

Peptic Ulcer Treatment Market @ https://www.biospace.com/article/rising-smoking-rates-and-aging-population-are-expected-to-drive-peptic-ulcer-treatment-market-growth-by-2030-reports-and-data/

Follicular Lymphoma Treatment Market @ https://www.biospace.com/article/rising-demand-for-medicines-related-to-the-treatment-of-follicular-lymphoma-is-expected-to-drive-follicular-lymphoma-treatment-market-growth-by-2030-reports-and-data/

Pseudomonas Aeruginosa Infection Treatment Market @ https://www.biospace.com/article/rising-patient-numbers-and-increase-in-public-knowledge-of-the-infection-are-expected-to-drive-pseudomonas-aeruginosa-infection-treatment-market-growth-by-2030-reports-and-data/

Brain Cancer Market @ https://www.biospace.com/article/increasing-advancement-and-novel-innovations-in-the-treatment-is-expected-to-drive-brain-cancer-market-growth-by-2030-reports-and-data/

Alpha Thalassemia Market @ https://www.biospace.com/article/increasing-prevalence-of-genetic-disorders-and-advancement-in-healthcare-technologies-and-treatments-are-majors-factors-driving-alpha-thalassemia-market-revenue-growth-by-2030-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com